Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Feasibility Study of T-Cell Depletion in Allogeneic Unrelated Bone Marrow Transplantation (MUD ALLO BMT) Followed by Delayed T-Cell Infusions

NCT00589602 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00589602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00589602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Feasibility Study of T-Cell Depletion in Allogeneic Unrelated Bone Marrow Transplantation (MUD ALLO BMT) Followed by Delayed T-Cell Infusions
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2004
Completion date
December 31, 2014
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, leukemia, lymphoma, multiple myeloma and malignant plasma cell neoplasms, myelodysplastic syndromes, precancerous/nonmalignant condition, secondary myelofibrosis